8th Annual USC Multidisciplinary Breast Cancer Symposium
2021 Updates on HER2+ MBC: What Does the New Data on T-DXd Suggest? Do Neratinib-Based Regimens Improve Outcomes in CNS Metastases? Is There a Clinical Benefit of Retreating Pts With Pertuzumab?
Comments 0
Login to view comments.
Click here to Login
